相似文献
1
Immunological evaluation of repeated administration of erythrocyte-entrapped protein to C3H/HeJ mice.
Biochem J. 1977 Nov 15;168(2):141-5. doi: 10.1042/bj1680141.
2
Immunologic aspects of enzyme replacement therapy. An evaluation of the immune response to unentrapped, erythrocyte- and liposome-entrapped enzyme in C3H/HeJ Gush mice.
Birth Defects Orig Artic Ser. 1980;16(1):163-78.
3
Enzyme therapy. V. In vivo fate of erythrocyte-entrapped beta-glucuronidase in beta-glucuronidase-deficient mice.
Pediatr Res. 1975 Dec;9(12):918-23. doi: 10.1203/00006450-197512000-00011.
4
Enzyme therapy XIV. Comparison of methods for enzyme entrapment in human erythrocytes.
J Lab Clin Med. 1980 Aug;96(2):307-17.
5
Acrylic microspheres in vivo V: Immunological properties of immobilized asparaginase in microparticles.
J Pharm Sci. 1982 May;71(5):576-80. doi: 10.1002/jps.2600710523.
6
The mouse immune response to carrier erythrocyte entrapped antigens.
Vaccine. 2006 Aug 28;24(35-36):6129-39. doi: 10.1016/j.vaccine.2006.05.013. Epub 2006 May 23.
7
Enzyme therapy. VI: Comparative in vivo fates and effects on lysosomal integrity of enzyme entrapped in negatively and positively charged liposomes.
Biochim Biophys Acta. 1977 Feb 4;464(3):530-46. doi: 10.1016/0005-2736(77)90028-1.
8
Enzyme therapy. X. Immune response induced by enzyme- and buffer-loaded liposomes in C3H/HeJ Gus(h) mice.
J Pharmacol Exp Ther. 1979 Mar;208(3):507-14.
9
Enzyme therapy XI: immunologic considerations for replacement therapy with unentrapped, erythrocyte- and liposome-entrapped enzymes.
Adv Exp Med Biol. 1978;101:753-64. doi: 10.1007/978-1-4615-9071-2_70.
10
Effective antigen delivery via dual entrapment in erythrocytes and autologous plasma beads.
J Drug Target. 2018 Feb;26(2):162-171. doi: 10.1080/1061186X.2017.1350859. Epub 2017 Jul 12.
引用本文的文献
1
Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice.
Am J Hum Genet. 2001 Jan;68(1):14-25. doi: 10.1086/316953. Epub 2000 Dec 13.
本文引用的文献
1
Recombinant inbred lines: value in the genetic analysis of biochemical variants.
Science. 1973 Sep 28;181(4106):1249-52. doi: 10.1126/science.181.4106.1249.
2
Factors controlling the resealing of the membrane of human erythrocyte ghosts after hypotonic hemolysis.
J Membr Biol. 1972;8(1):1-26. doi: 10.1007/BF01868092.
3
Enzyme therapy IV. A method for determining the in vivo fate of bovine beta-glucuronidase in beta-glucuronidase deficient mice.
Biochem Biophys Res Commun. 1974 Dec 23;61(4):1464-70. doi: 10.1016/s0006-291x(74)80448-1.
4
Caveat to protein replacement therapy for genetic disease. Immunological implications of accurate molecular diagnosis.
Lancet. 1973 Sep 22;2(7830):654-9. doi: 10.1016/s0140-6736(73)92489-6.
5
Enzyme therapy. V. In vivo fate of erythrocyte-entrapped beta-glucuronidase in beta-glucuronidase-deficient mice.
Pediatr Res. 1975 Dec;9(12):918-23. doi: 10.1203/00006450-197512000-00011.
6
Enzymatic degradation of uric acid by uricase-loaded human erythrocytes.
J Clin Invest. 1975 Sep;56(3):595-602. doi: 10.1172/JCI108129.
7
A comparison of intact human red blood cells and resealed and leaky ghosts with respect to their interactions with surface labelling agents and proteolytic enzymes.
Biochim Biophys Acta. 1975 Apr 8;382(4):621-33. doi: 10.1016/0005-2736(75)90227-8.
8
Enzyme replacement therapy in Gaucher's disease: a rapid, high-yield method for purification of glucocerebrosidase.
Proc Natl Acad Sci U S A. 1976 Dec;73(12):4672-4. doi: 10.1073/pnas.73.12.4672.
9
Enzyme therapy. Differential in vivo retention of bovine hepatic, renal, and splenic beta-glucuronidases and evidence for enzyme stabilization by intermolecular exchange.
Arch Biochem Biophys. 1977 Mar;179(2):397-408. doi: 10.1016/0003-9861(77)90127-8.
10
A dialysis procedure for loading erythrocytes with enzymes and lipids.
Biochim Biophys Acta. 1977 Jan 24;496(1):136-45. doi: 10.1016/0304-4165(77)90121-0.
Zotero 插件